N/A
Completed N=30
Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study
Source: ClinicalTrials.gov NCT02846415 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: Adjusted Post-test Score of Montreal Cognitive Assessment Scale After 2 Months of Intervention — 8.84; 7.40 score on a scale
Summary
This study intends to use Play Intervention for Dementia (PID) to promote cognitive functions of people with early to moderate dementia.
This is a cluster randomized controlled trial aims to recruit 38 participants from two study sites. Participants will be randomly allocated into intervention or wait-list controlled groups. Both groups will receive the same content of PID programme at different time. The PID consists of 12 weekly sessions. Each session lasts for 45-75 minutes. The PID will be facilitated by a play specialist, trained elderly volunteers, and centre staffs. Cognitive functions will be evaluated with Montreal Cognitive Assessment, Fuld Object Memory Evaluation and Modified Verbal Fluency Test, conducted by a trained research assistant blinded to group allocation. Centre staffs (not involved in the PID) will be interviewed. Every alternate session will be video-taped for understanding the experience of the participants in the PID programme.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adjusted Post-test Score of Montreal Cognitive Assessment Scale After 2 Months of Intervention |
8.84; 7.40 | — |
| SECONDARY Adjusted Post-test Score of Fuld Object Memory Evaluation - Total Storage Score |
18.92; 13.00 | — |
| SECONDARY Adjusted Post-test Score of the Modified Verbal Fluency Test |
14.34; 13.16 | — |
Eligibility Criteria
Inclusion Criteria
- Community dwelling, at the age of 65 or above
- With a medical confirmed diagnosis of any type of dementia (such as Alzheimer's disease, vascular dementia, etc.).
- At the stage of early to moderate dementia, at the stage of 4-6 screened by Global Deterioration Scale
Exclusion Criteria
- Unable to sit independently and participate in table activities
- Physically unstable
- Dislikes group activity
Data sourced from ClinicalTrials.gov (NCT02846415). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.